echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > "Fudan Tumor" launched a new "Chinese operation" in the world, which cleverly solves the problem of recurrent laryngeal nerve repair after thyroid cancer surgery

    "Fudan Tumor" launched a new "Chinese operation" in the world, which cleverly solves the problem of recurrent laryngeal nerve repair after thyroid cancer surgery

    • Last Update: 2022-03-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com





    It is reported that the recurrent laryngeal nerve is an important nerve that controls the movement of the vocal cords in the human body



    In clinical practice, some patients with thyroid cancer had already "grown very large" when they came to see the doctor, and had seriously invaded the trachea and recurrent laryngeal nerve, and some patients with esophageal cancer had already had lymph nodes metastasized to the area of ​​the recurrent laryngeal nerve when they came to see the doctor



    At present, there are three main traditional repair methods after segmental resection of the recurrent laryngeal nerve: direct suture, resection of other nerves to bridge the stump of the recurrent laryngeal nerve, severing of the phrenic nerve or anastomosis of the loop of the hypoglossal nerve and the stump of the recurrent laryngeal nerve





    In recent years, Professor Ji Qinghai and Professor Wang Yulong from the Head and Neck Surgery Department of Fudan University Cancer Hospital have summed up a large number of clinical experience in complex thyroid cancer surgery.



    Professor Ji Qinghai said that this new surgical method sounds quite professional, but in fact the reason is very easy to understand



    According to statistics, more than 20 patients have been completed by this new operation method , and the effect is very good.
    The hoarseness of the patients has recovered to varying degrees within half a year
    .
    At the same time, Prof.
    Ji Qinghai and Prof.
    Wang Yulong also made a theoretical analysis and summary of this important innovative technique from the practical level .
    The official journal of the college, Head & Neck , features the world premiere article and surgical video as a cover article
    .
    During the submission process of the article, it was highly praised by the editor of the journal
    .
    After the publication, domestic and foreign counterparts expressed great approval for the surgical method.
    Professor Holsinger , Director of Head and Neck Surgery of Stanford University , Professor Fang Jugao, Vice Chairman of the Head and Neck Cancer Special Committee of China Anti-Cancer Association, and Director of Head and Neck Surgery of Beijing Tongren Hospital, etc.
    It is considered that this operation is one of the best methods for the repair of the segmental defect of the right recurrent laryngeal nerve, which is original and practical
    .


    It is reported that the Department of Head and Neck Surgery of Fudan University Cancer Hospital has always been committed to the innovation and practice of surgical methods
    .
    Honorary professor of the hospital and professor of head and neck surgery Wang Hongshi, who was the first in the world to design a subhyoid myocutaneous flap for the repair of head and neck tumor defects, and won the National Science and Technology Progress Award
    .
    In recent years, under the leadership of Professor Ji Qinghai and Director Wang Yu, he has always been committed to the innovation of the concept and technology of multidisciplinary comprehensive diagnosis and treatment of head and neck tumors, and has made a series of achievements in the comprehensive diagnosis and treatment of thyroid cancer.
    7,600 units, the first in the country
    .
    A number of thyroid cancer diagnosis and treatment concepts and surgical techniques independently innovated by the department have been promoted and used in dozens of domestic units, benefiting the majority of thyroid cancer patients
    .









     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.